My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
December 2017
WHO Declares Commitment to End TB by 2030
IDSA Participates in Global Conference

IDSA participated in the first WHO Global Ministerial Conference on Ending TB last month in Moscow, an event that brought together 1,000 participants including ministers of health and finance and civil society representatives from across the globe. The Moscow Declaration adopted by delegations attending the conference includes a commitment to concerted action toward ending tuberculosis by 2030. Actions will include scaled-up TB case-finding, research and development of new drug regimens, better diagnostics, and a safe and effective vaccine as well as patient-centered care and policies. The declaration is widely viewed as an important precursor to the United Nations High Level Meeting on Tuberculosis scheduled for September 2018.

An announcement by the so-called BRICS countries--Brazil, the Russian Federation, India, China and South Africa--about the creation of a collaborative research institute on tuberculosis was viewed as an important initiative to spur the development of new tools for TB prevention, diagnosis and treatment. IDSA offered comments (PDF) on the Moscow Declaration, many of which were incorporated into the final document, and will be engaged over the coming year to ensure that the United States government and the UN General Assembly provide leadership and resources to tackle the world’s leading infectious disease killer.

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:

CMS Updates: Diagnostics Reimbursement Cuts, Medicare Physician Fee Schedule, QPP & ID
Federal Funding Update
HHS Tick-borne Disease Working Group
WHO Declares Commitment to End TB by 2030
Science Speaks
HIVMA Medical Students Program
HIVMA Clinical Fellowship Program
Young Investigator Prizes Available for Human Immunology & Vaccine Research
The Year in Review
ID Fellowship Match Results: Interest in ID Holds Steady
Tax Reform Bills Pose Threats to Public Health, Medical Education, Coverage
Journal Club
Invest in Our Path Forward with the IDSA Foundation
Help Us Improve the IDSA and HIVMA Websites!
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.